Shaked S, Rokach L, Arbel R, Razi T, Tadmor T. Glucagon-like peptide-1 receptor agonist exposure is associated with lower secondary malignancy risk during watch-and-wait in chronic lymphocytic leukemia: a timevarying analysis. Haematologica; https://doi.org/10.3324/haematol.2026.301905 [Early view].